Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA CIPLA ORCHID PHARMA/
CIPLA
 
P/E (TTM) x 41.8 32.2 129.6% View Chart
P/BV x 7.7 5.2 148.9% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ORCHID PHARMA   CIPLA
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-23
CIPLA
Mar-23
ORCHID PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs4391,185 37.0%   
Low Rs273852 32.1%   
Sales per share (Unadj.) Rs163.1281.9 57.9%  
Earnings per share (Unadj.) Rs13.535.1 38.5%  
Cash flow per share (Unadj.) Rs27.049.7 54.3%  
Dividends per share (Unadj.) Rs08.50 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs168.7289.2 58.3%  
Shares outstanding (eoy) m40.82807.15 5.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.23.6 60.4%   
Avg P/E ratio x26.329.0 90.7%  
P/CF ratio (eoy) x13.220.5 64.3%  
Price / Book Value ratio x2.13.5 59.9%  
Dividend payout %024.2 0.0%   
Avg Mkt Cap Rs m14,522822,164 1.8%   
No. of employees `000NANA-   
Total wages/salary Rs m65438,301 1.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,659227,531 2.9%  
Other income Rs m1945,121 3.8%   
Total revenues Rs m6,853232,653 2.9%   
Gross profit Rs m1,23548,079 2.6%  
Depreciation Rs m54811,721 4.7%   
Interest Rs m3291,095 30.0%   
Profit before tax Rs m55240,384 1.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m012,029 0.0%   
Profit after tax Rs m55228,355 1.9%  
Gross profit margin %18.521.1 87.8%  
Effective tax rate %029.8 0.0%   
Net profit margin %8.312.5 66.6%  
BALANCE SHEET DATA
Current assets Rs m5,010168,051 3.0%   
Current liabilities Rs m3,71950,333 7.4%   
Net working cap to sales %19.451.7 37.5%  
Current ratio x1.33.3 40.3%  
Inventory Days Days5773 78.3%  
Debtors Days Days1,1807 18,124.2%  
Net fixed assets Rs m7,242117,318 6.2%   
Share capital Rs m4081,614 25.3%   
"Free" reserves Rs m6,478231,845 2.8%   
Net worth Rs m6,886233,460 2.9%   
Long term debt Rs m1,4880-   
Total assets Rs m12,252290,067 4.2%  
Interest coverage x2.737.9 7.1%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.50.8 69.3%   
Return on assets %7.210.2 70.9%  
Return on equity %8.012.1 66.1%  
Return on capital %10.517.8 59.2%  
Exports to sales %81.922.6 361.6%   
Imports to sales %37.68.9 423.1%   
Exports (fob) Rs m5,45251,516 10.6%   
Imports (cif) Rs m2,50120,202 12.4%   
Fx inflow Rs m5,45264,282 8.5%   
Fx outflow Rs m2,72620,202 13.5%   
Net fx Rs m2,72644,080 6.2%   
CASH FLOW
From Operations Rs m18332,377 0.6%  
From Investments Rs m-312-23,885 1.3%  
From Financial Activity Rs m312-9,583 -3.3%  
Net Cashflow Rs m183-968 -18.9%  

Share Holding

Indian Promoters % 69.8 13.4 520.0%  
Foreign collaborators % 0.0 20.0 -  
Indian inst/Mut Fund % 18.6 50.0 37.3%  
FIIs % 4.1 25.7 16.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.2 66.5 45.3%  
Shareholders   36,931 425,731 8.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Orchid Pharma vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Orchid Pharma vs Cipla Share Price Performance

Period Orchid Pharma Cipla S&P BSE HEALTHCARE
1-Day -0.40% 1.94% 1.18%
1-Month -14.06% 1.25% -0.75%
1-Year 173.54% 68.02% 61.82%
3-Year CAGR -23.64% 22.53% 18.16%
5-Year CAGR 184.58% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the Orchid Pharma share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Orchid Pharma hold a 69.8% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Orchid Pharma and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Orchid Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Orchid Pharma, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.